# Pharmacological Regulation of Fat Transport in Metabolic Syndrome

> **NCT00632840** · PHASE4 · COMPLETED · sponsor: **The University of Western Australia** · enrollment: 11 (actual)

## Conditions studied

- Obesity
- Lipid Disorders
- Hypertriglyceridemia
- Cardiovascular Disease

## Interventions

- **DRUG:** Atorvastatin and fenofibrate

## Key facts

- **NCT ID:** NCT00632840
- **Lead sponsor:** The University of Western Australia
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-06
- **Primary completion:** 2002-12
- **Final completion:** 2007-12
- **Target enrollment:** 11 (ACTUAL)
- **Last updated:** 2008-03-11

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00632840

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00632840, "Pharmacological Regulation of Fat Transport in Metabolic Syndrome". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00632840. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*